Literature DB >> 21402851

Evolution and spread of a multidrug-resistant Proteus mirabilis clone with chromosomal AmpC-type cephalosporinases in Europe.

M M D'Andrea1, E Literacka, A Zioga, T Giani, A Baraniak, J Fiett, E Sadowy, P T Tassios, G M Rossolini, M Gniadkowski, V Miriagou.   

Abstract

Proteus mirabilis isolates obtained in 1999 to 2008 from three European countries were analyzed; all carried chromosomal AmpC-type cephalosporinase bla(CMY) genes from a Citrobacter freundii origin (bla(CMY-2)-like genes). Isolates from Poland harbored several bla(CMY) genes (bla(CMY-4), bla(CMY-12), bla(CMY-14), bla(CMY-15), and bla(CMY-38) and the new gene bla(CMY-45)), while isolates from Italy and Greece harbored bla(CMY-16) only. Earlier isolates with bla(CMY-4) or bla(CMY-12), recovered in France from Greek and Algerian patients, were also studied. All isolates showed striking similarities. Their bla(CMY) genes resided within ISEcp1 transposition modules, named Tn6093, characterized by a 110-bp distance between ISEcp1 and bla(CMY), and identical fragments of both C. freundii DNA and a ColE1-type plasmid backbone. Moreover, these modules were inserted into the same chromosomal site, within the pepQ gene. Since ColE1 plasmids carrying ISEcp1 with similar C. freundii DNA fragments (Tn6114) had been identified earlier, it is likely that a similar molecule had mediated at some stage this DNA transfer between C. freundii and P. mirabilis. In addition, isolates with bla(CMY-12), bla(CMY-15), and bla(CMY-38) genes harbored a second bla(CMY) copy within a shorter ISEcp1 module (Tn6113), always inserted downstream of the ppiD gene. Sequence analysis of all mobile bla(CMY-2)-like genes indicated that those integrated in the P. mirabilis chromosome form a distinct cluster that may have evolved by the stepwise accumulation of mutations. All of these observations, coupled to strain typing data, suggest that the bla(CMY) genes studied here may have originated from a single ISEcp1-mediated mobilization-transfer-integration process, followed by the spread and evolution of a P. mirabilis clone over time and a large geographic area.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402851      PMCID: PMC3101460          DOI: 10.1128/AAC.01736-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Characterization of the IncA/C plasmid pCC416 encoding VIM-4 and CMY-4 beta-lactamases.

Authors:  Céline Colinon; Vivi Miriagou; Alessandra Carattoli; Francesco Luzzaro; Gian Maria Rossolini
Journal:  J Antimicrob Chemother       Date:  2007-05-31       Impact factor: 5.790

2.  CMY-31 and CMY-36 cephalosporinases encoded by ColE1-like plasmids.

Authors:  A Zioga; J M Whichard; S D Kotsakis; L S Tzouvelekis; E Tzelepi; V Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

3.  Detecting VIM-1 production in Proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test.

Authors:  V Miriagou; C C Papagiannitsis; E Tzelepi; J Bou Casals; N J Legakis; L S Tzouvelekis
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

4.  MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences.

Authors:  Sudhir Kumar; Masatoshi Nei; Joel Dudley; Koichiro Tamura
Journal:  Brief Bioinform       Date:  2008-04-16       Impact factor: 11.622

Review 5.  Updated functional classification of beta-lactamases.

Authors:  Karen Bush; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2009-12-07       Impact factor: 5.191

6.  Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals.

Authors:  Joanna Empel; Anna Baraniak; Elzbieta Literacka; Agnieszka Mrówka; Janusz Fiett; Ewa Sadowy; Waleria Hryniewicz; Marek Gniadkowski
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

7.  Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome.

Authors:  George L Daikos; Chris Kosmidis; Panayotis T Tassios; George Petrikkos; Alexandra Vasilakopoulou; Mina Psychogiou; Ioanna Stefanou; Athina Avlami; Nikolaos Katsilambros
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

8.  Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.

Authors:  Francesco Luzzaro; Gioconda Brigante; Marco Maria D'Andrea; Beatrice Pini; Tommaso Giani; Elisabetta Mantengoli; Gian Maria Rossolini; Antonio Toniolo
Journal:  Int J Antimicrob Agents       Date:  2008-12-17       Impact factor: 5.283

Review 9.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Complete genome sequence of uropathogenic Proteus mirabilis, a master of both adherence and motility.

Authors:  Melanie M Pearson; Mohammed Sebaihia; Carol Churcher; Michael A Quail; Aswin S Seshasayee; Nicholas M Luscombe; Zahra Abdellah; Claire Arrosmith; Becky Atkin; Tracey Chillingworth; Heidi Hauser; Kay Jagels; Sharon Moule; Karen Mungall; Halina Norbertczak; Ester Rabbinowitsch; Danielle Walker; Sally Whithead; Nicholas R Thomson; Philip N Rather; Julian Parkhill; Harry L T Mobley
Journal:  J Bacteriol       Date:  2008-03-28       Impact factor: 3.490

View more
  21 in total

1.  High prevalence of extended-spectrum-cephalosporin-resistant enterobacteriaceae in poultry meat in Switzerland: emergence of CMY-2- and VEB-6-possessing Proteus mirabilis.

Authors:  Salome N Seiffert; Regula Tinguely; Agnese Lupo; Catherine Neuwirth; Vincent Perreten; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

2.  Detection of CMY-99, a novel acquired AmpC-Type β-lactamase, and VIM-1 in Proteus mirabilis isolates in Bulgaria.

Authors:  Ines Schneider; Rumyana Markovska; Ylia Marteva-Proevska; Ivan Mitov; Boyka Markova; Adolf Bauernfeind
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

3.  Identification of CMY-2-type cephalosporinases in clinical isolates of Enterobacteriaceae by MALDI-TOF MS.

Authors:  C C Papagiannitsis; S D Kotsakis; Z Tuma; M Gniadkowski; V Miriagou; J Hrabak
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

4.  Characterization of a mobilizable IncQ plasmid encoding cephalosporinase CMY-4 in Escherichia coli.

Authors:  S D Kotsakis; L S Tzouvelekis; E Lebessi; A Doudoulakakis; T Bouli; E Tzelepi; V Miriagou
Journal:  Antimicrob Agents Chemother       Date:  2015-02-17       Impact factor: 5.191

5.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry meropenem hydrolysis assay with NH4HCO3, a reliable tool for direct detection of carbapenemase activity.

Authors:  Costas C Papagiannitsis; Vendula Študentová; Radoslaw Izdebski; Olga Oikonomou; Yvonne Pfeifer; Efthimia Petinaki; Jaroslav Hrabák
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

6.  Increased Hydrolysis of Oximino-β-Lactams by CMY-107, a Tyr199Cys Mutant Form of CMY-2 Produced by Escherichia coli.

Authors:  S D Kotsakis; V Miriagou; E E Vetouli; E Bozavoutoglou; E Lebessi; E Tzelepi; L S Tzouvelekis
Journal:  Antimicrob Agents Chemother       Date:  2015-10-05       Impact factor: 5.191

7.  Chromosomal integration and location on IncT plasmids of the blaCTX-M-2 gene in Proteus mirabilis clinical isolates.

Authors:  Sohei Harada; Yoshikazu Ishii; Tomoo Saga; Yuichi Kouyama; Kazuhiro Tateda; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

8.  Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Barbara Fiori; Angela Raffaella Losito; Tiziana D'Inzeo; Lara Campana; Alberto Ruggeri; Eugenia Di Meco; Elvira Liberto; Giovanni Fadda; Roberto Cauda; Teresa Spanu
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

9.  Molecular screening of antibiotic-resistant determinants among multidrug-resistant clinical isolates of Proteus mirabilis from SouthWest Nigeria.

Authors:  Olumuyiwa Samuel Alabi; Nuno Mendonça; Olufemi Ezekiel Adeleke; Gabriela Jorge da Silva
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

10.  Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings.

Authors:  F Freitas; E Machado; T G Ribeiro; Â Novais; L Peixe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-07       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.